Importantly, high ILT4 expression was more frequently observed in NSCLC patients with adverse clinical parameters and low OS, indicating ILT4 was a poor prognostic factor in NSCLC patients. The gene discussed is LILRB2; the disease is non-small cell lung carcinoma.